Target intelligence / Profile preview

Ribokinase (RK)

Target
RK
Molecular classification
Enzyme, Kinase, Transferase, Phosphofructokinase B family (PfkB family), Carbohydrate kinase
01

Overview

Ribokinase is an **enzyme** (EC 2.7.1.15) that catalyzes the phosphorylation of **D-ribose** to **D-ribose-5-phosphate** using **ATP** and magnesium as cofactors. This reaction is the **first step in ribose catabolism**, facilitating the entry of ribose into the **pentose phosphate pathway** and supporting the synthesis of nucleotides and histidine. Ribokinase belongs to the **phosphofructokinase B (PfkB) family**, also known as the RK family, which shares conserved sequence motifs and structural features. In humans, ribokinase (abbreviation: RK) is encoded by the RBKS gene. The enzyme's activity is essential for trapping ribose within the cell following uptake and for the metabolic recycling of ribose derived from nucleoside catabolism[1][2][3][4][5][6][8]. There are no well-established direct therapeutic drugs targeting ribokinase, nor are there clear safety issues or biomarker roles reported in current biomedical literature.

Other names
d-RibokinaseATP:d-ribose 5-phosphotransferasedeoxyribokinaseribokinase (phosphorylating)
02

Mechanism of action

Substrate phosphorylation (transfers a phosphate group from ATP to D-ribose, producing D-ribose-5-phosphate)[1][2][5][8] - Magnesium ion dependence for activity[2][8]

03

Biological functions

Phosphorylation of ribose to ribose-5-phosphateRibose catabolismEntry point for ribose into the pentose phosphate pathwayPreparation of ribose for nucleotide and histidine synthesis
04

Disease associations

Other (implicated in central carbon metabolism; no direct major disease association established)

Beyond the preview

Go deeper on Ribokinase (RK).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribokinase (RK).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call